A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Patients With T1DM
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 13 Apr 2018 Status changed from active, no longer recruiting to completed.
- 28 Mar 2018 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.
- 28 Mar 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.